UK Markets closed
  • NIKKEI 225

    29,639.40
    -200.31 (-0.67%)
     
  • HANG SENG

    24,221.54
    +122.40 (+0.51%)
     
  • CRUDE OIL

    70.51
    -0.05 (-0.07%)
     
  • GOLD FUTURES

    1,768.40
    -9.80 (-0.55%)
     
  • DOW

    34,258.32
    +338.48 (+1.00%)
     
  • BTC-GBP

    32,565.74
    -2,671.21 (-7.58%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • Nasdaq

    14,896.85
    +150.45 (+1.02%)
     
  • ^FTAS

    4,081.81
    +52.80 (+1.31%)
     

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) Online Seminar, August 25-26, 2021 - ResearchAndMarkets.com

·3-min read

DUBLIN, August 03, 2021--(BUSINESS WIRE)--The "Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)" training has been added to ResearchAndMarkets.com's offering.

The globalization of the pharmaceutical supply chain has resulted in the increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it also presents unique compliance risks, particularly since operations are not under your direct control. Compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious cGMP compliance and data integrity issues at foreign CMO sites.

If you use CMOs, your firm is fully responsible for product quality, safety, efficacy, and cGMP compliance. Furthermore, FDA has clearly stated that firms using CMOs will be held accountable for CMO compliance to cGMPs, as well as for CMO adherence to Sponsor regulatory commitments. Issues identified at your CMO may result in FDA 483s and/or Warning Letters issued to your firm. Therefore, it is imperative that your organization have a robust CMO management system. At the end of the day, your ability to provide proper quality oversight of CMOs is the key to assuring product safety and safeguarding your firm's compliance profile.

This seminar will help all personnel responsible for CMO oversight understand how to ensure effective quality oversight of CMOs- from start to finish. In-depth focus will be placed on Selection and Qualification, CMO Audits, Quality Agreements, Oversight of CMO Operations, and Review of Key CMO Records. Considerations for different types of manufacturing will be highlighted, and techniques for managing difficult CMO situations will be addressed. Techniques for assuring robust CMO Oversight programs in light of COVID-19 restrictions will also be discussed.

This is a practical how-to course, designed to provide participants with skills they can immediately apply to CMO oversight within their own organizations. Case studies will allow participants to practice skill sets in cooperation with the instructor.

Learning Objectives

Upon completing this course, participants should be able to:

  • Understand the CMO business model

  • Understand the regulatory requirements for CMO quality oversight

  • Understand how to structure your organization for effective CMO oversight

  • Understand key points for selecting and qualifying CMOs

  • Know how to prepare for and conduct CMO Audits

  • Know how to develop a Quality Agreement and how to execute it

  • Understand key points for reviewing CMO records

  • Know how to resolve issues identified in CMO records

  • Know how to manage CMOs on an ongoing basis

Key Topics Covered:

DAY 01 (7:30 AM TO 1:30 PM PDT)

The CMO Business Model

What is CMO Oversight?

CMO Oversight and COVID-19 Restrictions

Regulatory Requirements for CMO Oversight

FDA Expectations and Warning Letters

Structuring Your Organization for CMO Oversight

  • Manufacturing

  • Chemistry / Laboratory

  • Quality Assurance

  • Regulatory Affairs

  • Project Management

  • Group Exercise # 1 - Structuring Your Organization

CMO Selection and Qualification

  • Overall Considerations

  • Selection Criteria / Process

  • Qualification Criteria / Process

  • Evaluating CMOs vs. Selection / Qualification Criteria

  • Case Study # 2 - Example of Selection Scoring Matrix

CMO Audits (Remote Auditing Perspective)

  • Overall Considerations

  • Qualification vs. Routine Audits

  • CMO Questionnaires

  • Purpose of Questionnaires

  • Questionnaire Topics / Responses

  • Audit Planning

  • Audit Purpose / Scope

  • Audit Agenda

  • Audit Execution

  • Document Review / Interviews

  • Time Management

  • Audit Findings / CAPAs

  • Group Exercise # 3 - Audit Agenda

The Quality Agreement

  • Regulatory Requirements

  • General Elements of the Quality Agreement

  • Negotiating the Quality Agreement

  • Executing the Quality Agreement

  • Case Study # 4 - Quality Agreement: Key Pitfalls

DAY 02 (7:30 AM TO 1:30 PM PDT)

Getting to Know Your CMO

  • Understanding CMO Operations

  • Operational/Communication Style

  • Case Study # 5 - CMO Personality Types

Review of Key CMO Records

  • Batch Records

  • Change Controls

  • Deviation Investigations / CAPA

  • OOS Investigations

Hot Topic - Data Integrity

Ongoing CMO Oversight

  • Overall Considerations

  • Elements of Effective Ongoing CMO Oversight

For more information about this training visit https://www.researchandmarkets.com/r/5gni8g

View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005466/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting